MedPath
HSA Approval

BIFEN SUSPENSION 100 mg/5 ml (OTC Pack)

SIN11949P

BIFEN SUSPENSION 100 mg/5 ml (OTC Pack)

BIFEN SUSPENSION 100 mg/5 ml (OTC Pack)

May 23, 2002

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

M01AE01

ibuprofen

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

IBUPROFEN

100 mg/5 ml

Ibuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIFEN SUSPENSION 100 mg/5 ml (OTC Pack) - HSA Approval | MedPath